Literature DB >> 8935252

Substance abuse treatment for Ontario residents in the United States.

B Rush1, S Tyas, G Martin.   

Abstract

In Canada, individuals experiencing problems related to their alcohol and drug use receive treatment and rehabilitative care through services provided primarily through the publicly funded health and social service system. During the past decade, however, an increasing number of Canadians have received treatment for substance abuse at facilities located in the United States, with most of the cost for this treatment borne by the various provincial health insurance plans. This paper provides a comprehensive analysis of the Ontario experience of treatment for substance abuse in the United States. First, the policy and planning context for the use of American treatment programs by Ontario residents and the rationale for recent changes to the reimbursement guidelines for such out-of-country treatment is reviewed. Secondly, the major trends in utilization of American programs over the past decade will be described and comparisons drawn to trends in the development of Ontario's own treatment system. This information has been used to help guide the development of treatment services in Ontario. In addition, the data serve as a baseline to measure the impact of various policy and program initiatives recently introduced in Ontario to reduce the utilization of treatment resources based in the United States.

Entities:  

Mesh:

Year:  1996        PMID: 8935252

Source DB:  PubMed          Journal:  Addiction        ISSN: 0965-2140            Impact factor:   6.526


  2 in total

1.  The effect of the Ontario Bariatric Network on health services utilization after bariatric surgery: a retrospective cohort study.

Authors:  Ahmad Elnahas; Timothy D Jackson; Allan Okrainec; Peter C Austin; Chaim M Bell; David R Urbach
Journal:  CMAJ Open       Date:  2016-09-14

Review 2.  Cross-border healthcare: A review and applicability to North America during COVID-19.

Authors:  Lyndsay T Glass; Christopher M Schlachta; Jeff D Hawel; Ahmad I Elnahas; Nawar A Alkhamesi
Journal:  Health Policy Open       Date:  2022-01-10
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.